Table 2.
KP sites | All sites | |||||
---|---|---|---|---|---|---|
Outcome | Intervention % (95% CI) | Control % (95% CI) | p value | Intervention, % (95% CI) | Control, % (95% CI) | p value |
MOP use | 12.0% (11.6, 12.4) | 10.5% (10.1, 10.9) | < 0.001 | 10.6% (10.3, 11.0) | 9.3% (8.9, 9.7) | < 0.001 |
Mean percent of CVD drug fills using MOP* | 42% (41.0, 43.1) | 40% (38.6, 40.9) | < 0.01 | 42% (41.1, 43.2) | 40% (38.7,40.9) | < 0.01 |
*Not available at HPHC
DM, diabetes mellitus; HT, hypertension; DL, dyslipidemia; CVD, cardiovascular disease